The alarm goes off before sunrise, and Dr. Armin Spura is already checking time zones. In a few hours he’ll be on a flight again - this month it’s China; last month it was Europe. His calendar is a blur of airports, site visits, and client meetings, but when we finally catch him between trips and ask a simple question, “What do you love about BioDuro and this industry?", Armin doesn’t hesitate.
“I feel fortunate to be part of an industry that not only helps patients get better medicine faster but also acts as a bridge builder between cultures,” he says.
He doesn’t just work across borders; he speaks across them. Fluent in six languages, Armin will often switch mid-conversation into the language of the person he’s speaking with - a small gesture that helps build trust and encourages people to speak openly. That instinct to close distance is at the heart of how he leads BioDuro’s global teams.
As BioDuro marks its 30-year milestone, that bridge-building mindset feels especially timely. Armin, who joined as CEO just two years ago, is reflecting on the company’s legacy while helping shape its next chapter.
When we sit down with Armin to look back on BioDuro’s journey, he doesn’t speak in abstractions -he talks about scientists and sites, timelines and trade‑offs, about how decisions in a lab become solutions for patients. Through it all, one theme is constant: a scientist leading scientists, building a borderless high-performing organization by bringing cultures together.
Armin: Thirty years is a remarkable achievement in an industry defined by constant innovation, change and scientific breakthroughs. Over the past year, what has impressed me the most is how consistently BioDuro has delivered high-quality solutions as a trusted scientific partner to our clients. You see it in the long‑standing client relationships, and you feel it when you talk to our teams. They take pride in the fact that their work has quietly supported countless programs on their way to the clinic and ultimately into the hands of patients.
What also stands out is how the company has continuously expanded its scientific capabilities, starting with small molecules and expanding into multiple emerging modalities, we have kept asking, “What else do our partners need from us to get to the next milestone? What else are their key pain points we can help them address?”
Armin: My PhD training and frankly, my early years as a scientist, still shapes how I think every day. As a scientist, you learn to live with uncertainty. I am a very analytical person and follow the data even when it challenges our assumptions. I stay curious when an experiment or an initial solution fails, rather than being discouraged by it.
At BioDuro, that translates into a very data driven, questioning mindset: I want to understand the evidence behind a decision. I encourage teams to test and learn, and I see every setback as information we can use to improve.
Most importantly, I want to create an environment where our research teams feel heard and empowered, where good questions are valued as much as good answers, and where curiosity and problem-solving are part of everyday culture, not just words on a wall.
Armin earned his Ph.D. from Brown University in 2000
Armin: Growing up in Germany, studying in the US, and then working with teams across Europe, the US, and China taught me something very simple: the science may be global, but people experience it locally. The data on the slide can be identical, yet the way a team in Shanghai talks about risk or timelines can feel very different from a team in Boston or Munich.
Speaking several languages helps me literally and figuratively meet people where they are. It reminds me to listen first, to understand what a colleague is really saying behind the words, and only then try to build alignment. At BioDuro, with global teams, that mindset is essential if we want everyone to pull in the same direction.
We see the benefits of this every day. When we put scientists from different regions around the same (often virtual) table - people with different backgrounds and cultures and ways of thinking -we almost always end up with better, more creative solutions than any one group could have come up with on their own. And for me, that’s one of the most enjoyable parts of the job.
Armin: What excites me most is the chance to help our partners move faster in a way that’s very real for patients. In drug development, speed isn’t just a metric on a slide - every week or month saved can be the difference between a therapy reaching someone in time or arriving too late.
We’re seeing tremendous scientific momentum in peptide therapeutics, GLP‑1 and other metabolic disease targets, and antibody–drug conjugates, at the same time as aging populations are driving demand for better treatments. For me, the opportunity is to bring together the right expertise, infrastructure, and people across BioDuro so that when an innovator comes to us with a promising idea, we can get the idea executed in the fastest, most reliable path possible.
Armin: For me, the values that matter most are scientific excellence, integrity-a keen focus on our clients-and openness. Scientific excellence means we don’t take shortcuts on science, even when no one is looking. Integrity means we do the right thing for clients and patients, even when it costs us more time or money. And openness -across disciplines, sites, and cultures - means people feel safe to raise concerns, share bad news early, and bring new ideas to the table.
We work in a world where data security, ESG, and sustainability really matter to our partners, and they matter to us as people too. Our gold rating from EcoVadis is one signal that we hold ourselves to the same standards as the pharma and biotech companies we support. But the real test is in the everyday moments: how we document and share data, how we talk about a study that didn’t work, how we support a colleague who is under pressure.
As BioDuro steps into its next decade, I want us to be known as a global, integrated CRDMO that moves fast without cutting corners, that sees complexity as something we can solve together, and that never forgets there is a patient and a family at the end of everything we do.
Home
